Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2020

Open Access 01-12-2020 | Carcinoid Tumor | Case report

Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report

Authors: Samuel A. Kareff, Jonathan W. Lischalk, Rebecca Krochmal, Chul Kim

Published in: Journal of Medical Case Reports | Issue 1/2020

Login to get access

Abstract

Background

The abscopal effect was described as early as the 1950s, when untreated tumors demonstrated a response after radiation therapy was delivered to an untreated, distant site. The mechanisms underlying this global response to otherwise localized therapy remain unknown, though there is increasing evidence that increased antigen expression following ablative radiotherapy may play a role.

Case presentation

We report a case of a 69-year-old African American woman with a history of metastatic typical pulmonary carcinoid with multiple lung nodules who had a significant decrease in size of an untreated left upper lobe nodule after stereotactic body radiation therapy to an oligoprogressive left lower lobe lesion.

Conclusions

To our knowledge, this report describes the first case of an abscopal effect in a typical pulmonary carcinoid. Further research is needed regarding the mechanisms responsible for this finding and the role of combining radiation therapy and cancer immunotherapy in patients with pulmonary carcinoid tumors.
Literature
1.
go back to reference Cummings AL, Kaprealian TB, Sarantopoulos GP, Mendenhall MA, Goldman JW. An abscopal effect in a case of neuroendocrine atypical carcinoid lung cancer. Appl Radiat Oncol. 2017;6(3):38–9. Cummings AL, Kaprealian TB, Sarantopoulos GP, Mendenhall MA, Goldman JW. An abscopal effect in a case of neuroendocrine atypical carcinoid lung cancer. Appl Radiat Oncol. 2017;6(3):38–9.
2.
go back to reference Pelosi G, Sonzogni A, Harari S, et al. Classification of pulmonary neuroendocrine tumors: new insights. Transl Lung Cancer Res. 2017;6(5):513–29.CrossRef Pelosi G, Sonzogni A, Harari S, et al. Classification of pulmonary neuroendocrine tumors: new insights. Transl Lung Cancer Res. 2017;6(5):513–29.CrossRef
3.
go back to reference Herde RF, Kokeny KE, Reddy CB, et al. Primary pulmonary carcinoid tumor: a long-term single institution experience. Am J Clin Oncol. 2018;41(1):24–9.PubMedPubMedCentral Herde RF, Kokeny KE, Reddy CB, et al. Primary pulmonary carcinoid tumor: a long-term single institution experience. Am J Clin Oncol. 2018;41(1):24–9.PubMedPubMedCentral
4.
go back to reference Grass GD, Krishna N, Kim S. The immune mechanisms of abscopal effect in radiation therapy. Curr Probl Cancer. 2016;40(1):10–24.CrossRef Grass GD, Krishna N, Kim S. The immune mechanisms of abscopal effect in radiation therapy. Curr Probl Cancer. 2016;40(1):10–24.CrossRef
5.
go back to reference Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015;41(6):503–10.CrossRef Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015;41(6):503–10.CrossRef
6.
go back to reference Lusuer P, Chevalier F, Strefan D, et al. Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma. Tumori. 2017;103(3):217–22.CrossRef Lusuer P, Chevalier F, Strefan D, et al. Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma. Tumori. 2017;103(3):217–22.CrossRef
7.
go back to reference Barsky AR, Cengel KA, Katz SI, et al. First-ever abscopal effect after palliative radiotherapy and immuno-gene therapy for malignant pleural mesothelioma. Cureus. 2019;11(2):e4102.PubMedPubMedCentral Barsky AR, Cengel KA, Katz SI, et al. First-ever abscopal effect after palliative radiotherapy and immuno-gene therapy for malignant pleural mesothelioma. Cureus. 2019;11(2):e4102.PubMedPubMedCentral
8.
go back to reference Robinson CG, Tan D, Yu SS. Recent advances in Merkel cell carcinoma. F1000Res. 2019;8:F1000 Faculty Rev–1995.CrossRef Robinson CG, Tan D, Yu SS. Recent advances in Merkel cell carcinoma. F1000Res. 2019;8:F1000 Faculty Rev–1995.CrossRef
9.
go back to reference Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366:925–31.CrossRef Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366:925–31.CrossRef
10.
go back to reference Imam H, Eriksson B, Lukinius A, et al. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs. Acta Oncol. 1997;36(6):607–14.CrossRef Imam H, Eriksson B, Lukinius A, et al. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs. Acta Oncol. 1997;36(6):607–14.CrossRef
11.
go back to reference Mehnert JM, Bergsland E, O’Neil BH, et al. Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: results from the KEYNOTE-028 study. Cancer. 2020;126(13):3021–30.CrossRef Mehnert JM, Bergsland E, O’Neil BH, et al. Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: results from the KEYNOTE-028 study. Cancer. 2020;126(13):3021–30.CrossRef
12.
go back to reference Strosberg J, Mizuno N, Doi T, et al. Efficacy and safety of pembrolizumab in previously treated advanced neuroendocrine tumors: results from the phase II KEYNOTE-158 study. Clin Cancer Res. 2020;26(9):2124–30.CrossRef Strosberg J, Mizuno N, Doi T, et al. Efficacy and safety of pembrolizumab in previously treated advanced neuroendocrine tumors: results from the phase II KEYNOTE-158 study. Clin Cancer Res. 2020;26(9):2124–30.CrossRef
13.
go back to reference Demaria S, Golden EB, Formenti SC. Role of local radiation therapy in cancer immunotherapy. JAMA Oncol. 2015;1(9):1325–32.CrossRef Demaria S, Golden EB, Formenti SC. Role of local radiation therapy in cancer immunotherapy. JAMA Oncol. 2015;1(9):1325–32.CrossRef
14.
go back to reference Brooks ED, Chang JY. Time to abandon single-site irradiation for inducing abscopal effects. Nat Rev Clin Oncol. 2019;16(2):123–5.CrossRef Brooks ED, Chang JY. Time to abandon single-site irradiation for inducing abscopal effects. Nat Rev Clin Oncol. 2019;16(2):123–5.CrossRef
15.
go back to reference Abuodeh Y, Venkat P, Kim S. Systematic review of case reports on the abscopal effect. Curr Probl Cancer. 2016;40(1):25–37.CrossRef Abuodeh Y, Venkat P, Kim S. Systematic review of case reports on the abscopal effect. Curr Probl Cancer. 2016;40(1):25–37.CrossRef
Metadata
Title
Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report
Authors
Samuel A. Kareff
Jonathan W. Lischalk
Rebecca Krochmal
Chul Kim
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2020
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-020-02512-8

Other articles of this Issue 1/2020

Journal of Medical Case Reports 1/2020 Go to the issue